🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the efficacy of 6-week Eltrombopag to treat ...
Status
Completed
Location
Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences
Start Date
2018-12-04
Trial ID
NCT03664518
Treatments Being Tested
The purpose of this study is to assess the ability of eltrombopag to mainta...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10
Trial ID
NCT00529568
Treatments Being Tested
The investigators' purpose was to assess the feasibility of dosage individu...
Status
Recruiting
Location
Department of Pediatrics, the Affiliated Hospital of Xuzhou Medical University
Start Date
2016-01-31
Trial ID
NCT03844360
This is an open-label, non-randomized, fixed-sequence study. Subjects will ...
Status
Completed
Location
Ucsf Ctsi Crc
Start Date
2021-10-28
Trial ID
NCT04542382
Treatments Being Tested
The purpose of this study is to evaluate if a study drug called eltrombopag...
Status
Suspended
Location
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Start Date
2025-06-17
Trial ID
NCT06630221
Treatments Being Tested
The objective of the study is to estimate the response to eltrombopag based...
Status
Completed
Location
Angers Hospital
Start Date
2019-08-02
Trial ID
NCT03638817
Treatments Being Tested
A clinical study to evaluate the efficacy of a drug called eltrombopag in a...
Status
Completed
Location
Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi
Start Date
2016-02-24
Trial ID
NCT02402998
Treatments Being Tested
Poor graft function (PGF) after allogeneic hematopoietic cell transplantati...
Status
Terminated
Location
Hôpital Claude Huriez, CHU
Start Date
2019-09-05
Trial ID
NCT03948529
Treatments Being Tested
This open-label, repeat dosing study, TRA108057, will evaluate the efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00424177
Treatments Being Tested
The purpose of this project is to describe the pathophysiology of thrombocy...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2009-06
Trial ID
NCT00909363
Treatments Being Tested